Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Prince

Showing results (391-400 of 396) with videos related to

Pageof 40
Sort By:
You have reached the last page of results.This site can display upto 396 results.
The Journal of Clinical Investigation|December 25, 2019
HPV16 drives cancer immune escape via NLRX1-mediated degradation of STINGXiaobo Luo, Christopher R Donnelly, Wang Gong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2010
Tobacco use in human papillomavirus-positive advanced oropharynx cancer patients related to increased risk of distant metastases and tumor recurrenceJessica H Maxwell, Bhavna Kumar, Felix Y Feng, et al.
International Journal of Radiation Oncology, Biology, Physics|March 17, 2023
Initial Feasibility and Acute Toxicity Outcomes From a Phase 2 Trial of <sup>18</sup>F-Fluorodeoxyglucose Positron Emission Tomography Response-Based De-escalated Definitive Chemoradiotherapy for p16+ Oropharynx Cancer: A Planned Interim AnalysisSteven G Allen, Benjamin S Rosen, Madhava Aryal, et al.
International Journal of Radiation Oncology, Biology, Physics|October 18, 2007
Targeting apoptosis to overcome cisplatin resistance: a translational study in head and neck cancerJoshua A Bauer, Bhavna Kumar, Kitrina G Cordell, et al.
The Journal of Molecular Diagnostics : JMD|May 7, 2026
Validation of MyHPVscore: a high-performance HPV ctDNA lab developed testJordan Currie, Heather Walline, Colleen G Hochfelder, et al.
JCI Insight|March 22, 2024
ctDNA transiting into urine is ultrashort and facilitates noninvasive liquid biopsy of HPV+ oropharyngeal cancerChandan Bhambhani, Qing Kang, Daniel H Hovelson, et al.
Pageof 40

Showing results (391-400 of 396) with videos related to

Sort By:
Pageof 40
You have reached the last page of results.This site can display upto 396 results.
The Journal of Clinical Investigation|December 25, 2019
HPV16 drives cancer immune escape via NLRX1-mediated degradation of STINGXiaobo Luo, Christopher R Donnelly, Wang Gong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2010
Tobacco use in human papillomavirus-positive advanced oropharynx cancer patients related to increased risk of distant metastases and tumor recurrenceJessica H Maxwell, Bhavna Kumar, Felix Y Feng, et al.
International Journal of Radiation Oncology, Biology, Physics|March 17, 2023
Initial Feasibility and Acute Toxicity Outcomes From a Phase 2 Trial of <sup>18</sup>F-Fluorodeoxyglucose Positron Emission Tomography Response-Based De-escalated Definitive Chemoradiotherapy for p16+ Oropharynx Cancer: A Planned Interim AnalysisSteven G Allen, Benjamin S Rosen, Madhava Aryal, et al.
International Journal of Radiation Oncology, Biology, Physics|October 18, 2007
Targeting apoptosis to overcome cisplatin resistance: a translational study in head and neck cancerJoshua A Bauer, Bhavna Kumar, Kitrina G Cordell, et al.
The Journal of Molecular Diagnostics : JMD|May 7, 2026
Validation of MyHPVscore: a high-performance HPV ctDNA lab developed testJordan Currie, Heather Walline, Colleen G Hochfelder, et al.
JCI Insight|March 22, 2024
ctDNA transiting into urine is ultrashort and facilitates noninvasive liquid biopsy of HPV+ oropharyngeal cancerChandan Bhambhani, Qing Kang, Daniel H Hovelson, et al.
Pageof 40